BioCentury | Jul 11, 2016
Financial News

InspireMD completes private placement of convertible preferred stock and warrants

InspireMD Inc. (NYSE-M:NSPR), Tel Aviv, Israel Business: Cardiovascular Date completed: 2016-06-30 Type: Private placement of convertible preferred stock and warrants Raised: $14.6 million Shares: 442,424 Price: $33 Shares outstanding prior: 10.7 million Placement agent: Dawson...
BioCentury | Jun 27, 2016
Financial News

InspireMD amends private placement of convertible preferred stock and warrants

...Shares: 385,715 Price Prior: $0.57 Shares outstanding prior: 10.7 million Underwriter: Dawson James Securities Note: InspireMD...
BioCentury | May 30, 2016
Financial News

InspireMD amends private placement of convertible preferred stock and warrants

...Shares: 39,706 Price prior: $0.57 Shares outstanding prior: 10.7 million Underwriter: Dawson James Securities Note: InspireMD...
BioCentury | Apr 18, 2016
Financial News

InspireMD proposes private placement of convertible preferred stock and warrants

InspireMD Inc. (NYSE-M:NSPR), Tel Aviv, Israel Business: Cardiovascular Date announced: 2016-04-14 Type: Private placement of convertible preferred stock and warrants To be raised: TBD Shares: TBD Price prior: $0.57 Shares outstanding prior: 10.7 million Underwriter:...
BioCentury | Apr 4, 2016
Finance

Fundamental reset

...$14.1 $75.4 $82.4 9% Hutchison China MediTech Ltd. (LSE:HCM; NASDAQ:HCM) 3/17/16 $101.3 $1,627.6 $1,591.5 -2% InspireMD Inc....
BioCentury | Mar 21, 2016
Financial News

InspireMD completes follow-on

InspireMD Inc. (NYSE-M:NSPR), Tel Aviv, Israel Business: Cardiovascular Date completed: 2016-03-16 Type: Follow-on Raised: $1.1 million Shares: 1.9 million Price: $0.59 Shares after offering: 10.7 million Underwriter: Dawson James Securities Overallotment: 1 million Note: Each...
BioCentury | Mar 21, 2016
Financial News

InspireMD completes private placement of common stock and warrants

InspireMD Inc. (NYSE-M:NSPR), Tel Aviv, Israel Business: Cardiovascular Date completed: 2016-03-16 Type: Private placement of common stock and warrants Raised: $609,500 Shares: 1 million Price: $0.59 Shares after offering: 10.7 million Investors: Company management; company...
BioCentury | Mar 9, 2015
Financial News

InspireMD completes private placement of common stock and warrants

InspireMD Inc. (NYSE-M:NSPR), Tel Aviv, Israel Business: Cardiovascular Date completed: 2015-03-04 Type: Private placement of common stock and warrants Raised: $13.8 million Shares: 34.5 million Price: $0.40 Shares after offering: 78.3 million Underwriters: H.C. Wainwright;...
BioCentury | Nov 10, 2014
Financial News

InspireMD completes direct public offering

InspireMD Inc. (NYSE-M:NSPR), Tel Aviv, Israel Business: Cardiovascular Date completed: 2014-11-04 Type: Direct public offering Raised: $8.1 million Shares: 6.3 million Price: $1.30 Shares after offering: 42.4 million Placement agent: H.C. Wainwright Note: Investors received...
BioCentury | Jul 1, 2013
Finance

3Q Financial Markets Preview: Window watching

...NASDAQ:CCXI) 4/16/13 $69.0 $511.1 $602.6 18% Durata Therapeutics Inc. (NASDAQ:DRTX) 4/12/13 $57.6 $186.4 $191.7 3% InspireMD Inc....
Items per page:
1 - 10 of 18
BioCentury | Jul 11, 2016
Financial News

InspireMD completes private placement of convertible preferred stock and warrants

InspireMD Inc. (NYSE-M:NSPR), Tel Aviv, Israel Business: Cardiovascular Date completed: 2016-06-30 Type: Private placement of convertible preferred stock and warrants Raised: $14.6 million Shares: 442,424 Price: $33 Shares outstanding prior: 10.7 million Placement agent: Dawson...
BioCentury | Jun 27, 2016
Financial News

InspireMD amends private placement of convertible preferred stock and warrants

...Shares: 385,715 Price Prior: $0.57 Shares outstanding prior: 10.7 million Underwriter: Dawson James Securities Note: InspireMD...
BioCentury | May 30, 2016
Financial News

InspireMD amends private placement of convertible preferred stock and warrants

...Shares: 39,706 Price prior: $0.57 Shares outstanding prior: 10.7 million Underwriter: Dawson James Securities Note: InspireMD...
BioCentury | Apr 18, 2016
Financial News

InspireMD proposes private placement of convertible preferred stock and warrants

InspireMD Inc. (NYSE-M:NSPR), Tel Aviv, Israel Business: Cardiovascular Date announced: 2016-04-14 Type: Private placement of convertible preferred stock and warrants To be raised: TBD Shares: TBD Price prior: $0.57 Shares outstanding prior: 10.7 million Underwriter:...
BioCentury | Apr 4, 2016
Finance

Fundamental reset

...$14.1 $75.4 $82.4 9% Hutchison China MediTech Ltd. (LSE:HCM; NASDAQ:HCM) 3/17/16 $101.3 $1,627.6 $1,591.5 -2% InspireMD Inc....
BioCentury | Mar 21, 2016
Financial News

InspireMD completes follow-on

InspireMD Inc. (NYSE-M:NSPR), Tel Aviv, Israel Business: Cardiovascular Date completed: 2016-03-16 Type: Follow-on Raised: $1.1 million Shares: 1.9 million Price: $0.59 Shares after offering: 10.7 million Underwriter: Dawson James Securities Overallotment: 1 million Note: Each...
BioCentury | Mar 21, 2016
Financial News

InspireMD completes private placement of common stock and warrants

InspireMD Inc. (NYSE-M:NSPR), Tel Aviv, Israel Business: Cardiovascular Date completed: 2016-03-16 Type: Private placement of common stock and warrants Raised: $609,500 Shares: 1 million Price: $0.59 Shares after offering: 10.7 million Investors: Company management; company...
BioCentury | Mar 9, 2015
Financial News

InspireMD completes private placement of common stock and warrants

InspireMD Inc. (NYSE-M:NSPR), Tel Aviv, Israel Business: Cardiovascular Date completed: 2015-03-04 Type: Private placement of common stock and warrants Raised: $13.8 million Shares: 34.5 million Price: $0.40 Shares after offering: 78.3 million Underwriters: H.C. Wainwright;...
BioCentury | Nov 10, 2014
Financial News

InspireMD completes direct public offering

InspireMD Inc. (NYSE-M:NSPR), Tel Aviv, Israel Business: Cardiovascular Date completed: 2014-11-04 Type: Direct public offering Raised: $8.1 million Shares: 6.3 million Price: $1.30 Shares after offering: 42.4 million Placement agent: H.C. Wainwright Note: Investors received...
BioCentury | Jul 1, 2013
Finance

3Q Financial Markets Preview: Window watching

...NASDAQ:CCXI) 4/16/13 $69.0 $511.1 $602.6 18% Durata Therapeutics Inc. (NASDAQ:DRTX) 4/12/13 $57.6 $186.4 $191.7 3% InspireMD Inc....
Items per page:
1 - 10 of 18